Does DANAZOL Cause Hepatocellular carcinoma? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatocellular carcinoma have been filed in association with DANAZOL (Danazol). This represents 1.3% of all adverse event reports for DANAZOL.
6
Reports of Hepatocellular carcinoma with DANAZOL
1.3%
of all DANAZOL reports
1
Deaths
3
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From DANAZOL?
Of the 6 reports, 1 (16.7%) resulted in death, 3 (50.0%) required hospitalization, and 2 (33.3%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DANAZOL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DANAZOL Cause?
Drug ineffective (155)
Hepatic enzyme increased (95)
Nausea (94)
Neutropenia (88)
Constipation (87)
Coombs positive haemolytic anaemia (87)
Haemolysis (87)
Infusion related reaction (87)
Lymphadenitis (87)
Migraine (86)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which DANAZOL Alternatives Have Lower Hepatocellular carcinoma Risk?
DANAZOL vs DANICOPAN
DANAZOL vs DANTROLENE
DANAZOL vs DAPAGLIFLOZIN
DANAZOL vs DAPAGLIFLOZIN PROPANEDIOL
DANAZOL vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN